GSK Pharma inches ahead after good Q4 numbers

GSK Pharma inches ahead after good Q4 numbers

GlaxoSmithKline Pharmaceuticals gained 0.39% to Rs 937 at 13:03 IST on BSE on reporting 19.34% rise in net profit to Rs 80.9 crore in Q4 December 2007 over Q4 December 2006.

The results were announced during trading hours today, 22 February 2008. Meanwhile, BSE Sensex was down 296.13 points or 1.67% to 17,438.55, as US and Asian stock markets fell on heightened fears of a US recession.

On BSE, 1.54 lakh shares were traded in the counter. The scrip had an average daily volume of 21,768 shares in the past one quarter.

The stock hit a high of Rs 963.95 and low of Rs 915.15 so far during the day. The stock had a 52-week high of Rs 1340 on 4 June 2007 and a 52-week low of Rs 800 on 22 January 2008.

The mid-cap scrip had outperformed the market over the past one month till 21 February 2008, gaining 6.44% compared to the Sensex's return of 0.80%. It had underperformed the market in the past one quarter, declining 9.70% compared to Sensex's decline of 5.93%.

The company's current equity is Rs 84.70 crore. Face value per share is Rs 10.

The current price of Rs 937 discounts its Q3 September 2007 annualized EPS of Rs 117.60, by a PE multiple of 7.97.

GlaxoSmithKline Pharmaceuticals' total income rose 7.45% to Rs 367.94 crore in Q4 December 2007 over Q4 December 2006.

The company is engaged in manufacturing and marketing pharmaceutical and healthcare products